Am J Transplant, Volume 21, Suppl 3 Archives - Page 32 of 139 - ATC Abstracts

2021 American Transplant Congress
Risk Factors Associated with Multidrug Resistant Organism (MDRO) Infections in Kidney Transplant Recipients: A Single Center Experience
S. Schrank¹, J. Timpone², B. Javaid³, P. Kumar², M. Cooper³
¹Internal Medicine, MedStar Georgetown University Hospital, Washington, DC, ²Infectious Diseases and Travel Medicine, MedStar Georgetown University Hospital, Washington, DC, ³Transplant Institute, MedStar Georgetown University Hospital, Washington, DC
*Purpose: Risk factors for MDRO infections in kidney transplant recipients have previously been studied but limited to urinary tract infections. We sought to evaluate the…
2021 American Transplant Congress
Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single Center Experience
M. Carter¹, M. Fitzmaurice², S. Yeddula², A. Singh², S. Nagai², S. Jafri²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Health System, Detroit, MI
*Purpose: Transplant-related Hepatitis E virus (HEV) infection is a rarely recognized entity with significant clinical importance given potential for chronic hepatitis post-transplant. We evaluated HEV…
2021 American Transplant Congress
Impact of the Kidney Allocation System on Kidney Transplant Outcomes in Patients with Long Dialysis Treatment (> 10 Years)
M. Kadatz, S. Vaishnav, S. Brar, D. Chang, J. Lan, J. Gill
Medicine, Division of Nephrology, University of British Columbia, Vancouver, BC, Canada
*Purpose: Prior to the new kidney allocation system (KAS), patients treated with dialysis for > 10 years before transplantation were shown to derive a survival…
2021 American Transplant Congress
Impact of Elevated Initial Donor Creatinine on Outcomes After Transplanting Kidney from Deceased Donor with Severe AKI
L. Kodali, K. Reddy, P. Budhiraja, S. Nair, G. Mour, J. Huskey, C. Jadloweic, H. Khamash, H. Chakkera, R. Heilman
Medicine, Mayo Clinic, Arizona, Phoenix, AZ
*Purpose: Several studies have shown good outcomes with transplanting kidneys from deceased donors with AKI; however, the impact of having elevated initial donor creatinine has…
2021 American Transplant Congress
Poor Reliability of Karnofsky Performance Score in Kidney Transplant Candidates
M. R. Stedman, D. J. Watford, G. M. Chertow, J. C. Tan
Medicine, Stanford University, Palo Alto, CA
*Purpose: The Karnofsky Performance Status (KPS) Scale has been used as a proxy for frailty and as a predictor of transplant outcomes, however reliability of…
2021 American Transplant Congress
Covid-19-related Knowledge, Health Behaviors and Attitudes Towards Telemedicine and Emergency Visits in a Population of Kidney Transplant (KTx) Recipients
A. Lin, M. Saw-Aung, W. Yang, G. Udod, A. Imas, M. Markell
SUNY Downstate Health Sciences University, Brooklyn, NY
*Purpose: We explored knowledge about COVID-19 and attitudes towards emergency care and telemedicine visits in a population of inner-city KTx pts.*Methods: A telephone survey was…
2021 American Transplant Congress
Risk of Statin-Related Side Effects in Kidney Transplant Recipients
S. Bae¹, J. Ahn¹, K. Lentine², M. A. Schnitzler², G. Hess³, H. Xiao², D. Segev¹, M. McAdams DeMarco¹
¹Johns Hopkins University, Baltimore, MD, ²Saint Louis University, Saint Louis, MO, ³Drexel University, Philadelphia, PA
*Purpose: Statins are widely used in kidney transplant (KT) recipients for prevention of cardiovascular events. Statins’ safety profile may differ in KT recipients due to…
2021 American Transplant Congress
Clinical Effect of Post-transplant Av-fistula Ligation on Hemodynamic Status and Kidney Allograft Function
S. Valavoor, J. Powelson, A. Sharfuddin, O. Adebiyi
Nephrology, Indiana University, Indianapolis, IN
*Purpose: Ligation of AVF post kidney transplant often done mostly for esthetic reasons, however, they are occasionally indicated in the presence severe steal syndrome, severe…
2021 American Transplant Congress
Outcomes in Standard vs. Extended Use of Thymoglobulin as Induction Therapy in Kidney Transplant Recipients
N. M. Sifontis¹, A. Coleman¹, D. Tang¹, K. Lau², S. Karhadkar², A. DiCarlo², A. Diamond²
¹Temple University School of Pharmacy, Philadelphia, PA, ²Temple University Health System, Philadelphia, PA
*Purpose: Thymoglobulin induction along with modern maintenance immunosuppression has been found to have a significant reduction in acute rejection in kidney transplantation. The recommended duration…
2021 American Transplant Congress
Obesity Impacts Acute Rejection but Not Allograft Function Improvement in the Setting of Belatacept Conversion
D. Pierce, J. Benken, P. West-Thielke, I. Tzvetanov, E. Benedetti, A. Lichvar
University of Illinois at Chicago, Chicago, IL
*Purpose: There is limited data regarding belatacept conversion in obese patients as an alternative to calcineurin inhibitor (CNI) immunosuppression. Pharmacokinetic (PK) data suggests increasing clearance…